Global Influenza Vaccination Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Influenza Vaccination market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
The Global Info Research report includes an overview of the development of the Influenza Vaccination industry chain, the market status of Hospitals (Egg Based, Cell Culture), Research Organizations (Egg Based, Cell Culture), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Vaccination.
Regionally, the report analyzes the Influenza Vaccination markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Vaccination market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Vaccination market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Vaccination industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Egg Based, Cell Culture).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Vaccination market.
Regional Analysis: The report involves examining the Influenza Vaccination market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Vaccination market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Vaccination:
Company Analysis: Report covers individual Influenza Vaccination players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Vaccination This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Research Organizations).
Technology Analysis: Report covers specific technologies relevant to Influenza Vaccination. It assesses the current state, advancements, and potential future developments in Influenza Vaccination areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Vaccination market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Vaccination market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Influenza Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Vaccination, with revenue, gross margin and global market share of Influenza Vaccination from 2019 to 2024.
Chapter 3, the Influenza Vaccination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Influenza Vaccination market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Vaccination.
Chapter 13, to describe Influenza Vaccination research findings and conclusion.
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
The Global Info Research report includes an overview of the development of the Influenza Vaccination industry chain, the market status of Hospitals (Egg Based, Cell Culture), Research Organizations (Egg Based, Cell Culture), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Vaccination.
Regionally, the report analyzes the Influenza Vaccination markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Vaccination market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Vaccination market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Vaccination industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Egg Based, Cell Culture).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Vaccination market.
Regional Analysis: The report involves examining the Influenza Vaccination market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Vaccination market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Vaccination:
Company Analysis: Report covers individual Influenza Vaccination players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Vaccination This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Research Organizations).
Technology Analysis: Report covers specific technologies relevant to Influenza Vaccination. It assesses the current state, advancements, and potential future developments in Influenza Vaccination areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Vaccination market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Vaccination market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Egg Based
- Cell Culture
- Recombinant
- Hospitals
- Research Organizations
- Abbott (U.S.)
- AstraZeneca (Europe)
- BioCryst Pharmaceuticals (U.S.)
- Novartis (Europe)
- DAIICHI SANKYO COMPANY (Asia Pacific)
- GlaxoSmithKline (Europe)
- Hualan Biological Engineering (Asia Pacific)
- Mitsubishi Tanabe Pharma (Asia Pacific)
- F. Hoffmann-La Roche (Europe)
- Sanofi (Europe)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Influenza Vaccination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Vaccination, with revenue, gross margin and global market share of Influenza Vaccination from 2019 to 2024.
Chapter 3, the Influenza Vaccination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Influenza Vaccination market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Vaccination.
Chapter 13, to describe Influenza Vaccination research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Influenza Vaccination
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Vaccination by Type
1.3.1 Overview: Global Influenza Vaccination Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Influenza Vaccination Consumption Value Market Share by Type in 2023
1.3.3 Egg Based
1.3.4 Cell Culture
1.3.5 Recombinant
1.4 Global Influenza Vaccination Market by Application
1.4.1 Overview: Global Influenza Vaccination Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Research Organizations
1.5 Global Influenza Vaccination Market Size & Forecast
1.6 Global Influenza Vaccination Market Size and Forecast by Region
1.6.1 Global Influenza Vaccination Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Influenza Vaccination Market Size by Region, (2019-2030)
1.6.3 North America Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.4 Europe Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.6 South America Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Influenza Vaccination Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott (U.S.)
2.1.1 Abbott (U.S.) Details
2.1.2 Abbott (U.S.) Major Business
2.1.3 Abbott (U.S.) Influenza Vaccination Product and Solutions
2.1.4 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott (U.S.) Recent Developments and Future Plans
2.2 AstraZeneca (Europe)
2.2.1 AstraZeneca (Europe) Details
2.2.2 AstraZeneca (Europe) Major Business
2.2.3 AstraZeneca (Europe) Influenza Vaccination Product and Solutions
2.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca (Europe) Recent Developments and Future Plans
2.3 BioCryst Pharmaceuticals (U.S.)
2.3.1 BioCryst Pharmaceuticals (U.S.) Details
2.3.2 BioCryst Pharmaceuticals (U.S.) Major Business
2.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
2.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.4 Novartis (Europe)
2.4.1 Novartis (Europe) Details
2.4.2 Novartis (Europe) Major Business
2.4.3 Novartis (Europe) Influenza Vaccination Product and Solutions
2.4.4 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis (Europe) Recent Developments and Future Plans
2.5 DAIICHI SANKYO COMPANY (Asia Pacific)
2.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Details
2.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
2.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
2.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
2.6 GlaxoSmithKline (Europe)
2.6.1 GlaxoSmithKline (Europe) Details
2.6.2 GlaxoSmithKline (Europe) Major Business
2.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
2.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline (Europe) Recent Developments and Future Plans
2.7 Hualan Biological Engineering (Asia Pacific)
2.7.1 Hualan Biological Engineering (Asia Pacific) Details
2.7.2 Hualan Biological Engineering (Asia Pacific) Major Business
2.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
2.7.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma (Asia Pacific)
2.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Details
2.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
2.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
2.9 F. Hoffmann-La Roche (Europe)
2.9.1 F. Hoffmann-La Roche (Europe) Details
2.9.2 F. Hoffmann-La Roche (Europe) Major Business
2.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
2.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
2.10 Sanofi (Europe)
2.10.1 Sanofi (Europe) Details
2.10.2 Sanofi (Europe) Major Business
2.10.3 Sanofi (Europe) Influenza Vaccination Product and Solutions
2.10.4 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sanofi (Europe) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Vaccination Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Influenza Vaccination by Company Revenue
3.2.2 Top 3 Influenza Vaccination Players Market Share in 2023
3.2.3 Top 6 Influenza Vaccination Players Market Share in 2023
3.3 Influenza Vaccination Market: Overall Company Footprint Analysis
3.3.1 Influenza Vaccination Market: Region Footprint
3.3.2 Influenza Vaccination Market: Company Product Type Footprint
3.3.3 Influenza Vaccination Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Vaccination Consumption Value and Market Share by Type (2019-2024)
4.2 Global Influenza Vaccination Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Vaccination Consumption Value Market Share by Application (2019-2024)
5.2 Global Influenza Vaccination Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Influenza Vaccination Consumption Value by Type (2019-2030)
6.2 North America Influenza Vaccination Consumption Value by Application (2019-2030)
6.3 North America Influenza Vaccination Market Size by Country
6.3.1 North America Influenza Vaccination Consumption Value by Country (2019-2030)
6.3.2 United States Influenza Vaccination Market Size and Forecast (2019-2030)
6.3.3 Canada Influenza Vaccination Market Size and Forecast (2019-2030)
6.3.4 Mexico Influenza Vaccination Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Influenza Vaccination Consumption Value by Type (2019-2030)
7.2 Europe Influenza Vaccination Consumption Value by Application (2019-2030)
7.3 Europe Influenza Vaccination Market Size by Country
7.3.1 Europe Influenza Vaccination Consumption Value by Country (2019-2030)
7.3.2 Germany Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.3 France Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.5 Russia Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.6 Italy Influenza Vaccination Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Vaccination Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Influenza Vaccination Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Influenza Vaccination Market Size by Region
8.3.1 Asia-Pacific Influenza Vaccination Consumption Value by Region (2019-2030)
8.3.2 China Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.3 Japan Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.4 South Korea Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.5 India Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.7 Australia Influenza Vaccination Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Influenza Vaccination Consumption Value by Type (2019-2030)
9.2 South America Influenza Vaccination Consumption Value by Application (2019-2030)
9.3 South America Influenza Vaccination Market Size by Country
9.3.1 South America Influenza Vaccination Consumption Value by Country (2019-2030)
9.3.2 Brazil Influenza Vaccination Market Size and Forecast (2019-2030)
9.3.3 Argentina Influenza Vaccination Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Vaccination Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Influenza Vaccination Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Influenza Vaccination Market Size by Country
10.3.1 Middle East & Africa Influenza Vaccination Consumption Value by Country (2019-2030)
10.3.2 Turkey Influenza Vaccination Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Influenza Vaccination Market Size and Forecast (2019-2030)
10.3.4 UAE Influenza Vaccination Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Influenza Vaccination Market Drivers
11.2 Influenza Vaccination Market Restraints
11.3 Influenza Vaccination Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Vaccination Industry Chain
12.2 Influenza Vaccination Upstream Analysis
12.3 Influenza Vaccination Midstream Analysis
12.4 Influenza Vaccination Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Influenza Vaccination
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Vaccination by Type
1.3.1 Overview: Global Influenza Vaccination Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Influenza Vaccination Consumption Value Market Share by Type in 2023
1.3.3 Egg Based
1.3.4 Cell Culture
1.3.5 Recombinant
1.4 Global Influenza Vaccination Market by Application
1.4.1 Overview: Global Influenza Vaccination Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Research Organizations
1.5 Global Influenza Vaccination Market Size & Forecast
1.6 Global Influenza Vaccination Market Size and Forecast by Region
1.6.1 Global Influenza Vaccination Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Influenza Vaccination Market Size by Region, (2019-2030)
1.6.3 North America Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.4 Europe Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.6 South America Influenza Vaccination Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Influenza Vaccination Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott (U.S.)
2.1.1 Abbott (U.S.) Details
2.1.2 Abbott (U.S.) Major Business
2.1.3 Abbott (U.S.) Influenza Vaccination Product and Solutions
2.1.4 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott (U.S.) Recent Developments and Future Plans
2.2 AstraZeneca (Europe)
2.2.1 AstraZeneca (Europe) Details
2.2.2 AstraZeneca (Europe) Major Business
2.2.3 AstraZeneca (Europe) Influenza Vaccination Product and Solutions
2.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca (Europe) Recent Developments and Future Plans
2.3 BioCryst Pharmaceuticals (U.S.)
2.3.1 BioCryst Pharmaceuticals (U.S.) Details
2.3.2 BioCryst Pharmaceuticals (U.S.) Major Business
2.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
2.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.4 Novartis (Europe)
2.4.1 Novartis (Europe) Details
2.4.2 Novartis (Europe) Major Business
2.4.3 Novartis (Europe) Influenza Vaccination Product and Solutions
2.4.4 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis (Europe) Recent Developments and Future Plans
2.5 DAIICHI SANKYO COMPANY (Asia Pacific)
2.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Details
2.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
2.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
2.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
2.6 GlaxoSmithKline (Europe)
2.6.1 GlaxoSmithKline (Europe) Details
2.6.2 GlaxoSmithKline (Europe) Major Business
2.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
2.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline (Europe) Recent Developments and Future Plans
2.7 Hualan Biological Engineering (Asia Pacific)
2.7.1 Hualan Biological Engineering (Asia Pacific) Details
2.7.2 Hualan Biological Engineering (Asia Pacific) Major Business
2.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
2.7.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma (Asia Pacific)
2.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Details
2.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
2.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
2.9 F. Hoffmann-La Roche (Europe)
2.9.1 F. Hoffmann-La Roche (Europe) Details
2.9.2 F. Hoffmann-La Roche (Europe) Major Business
2.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
2.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
2.10 Sanofi (Europe)
2.10.1 Sanofi (Europe) Details
2.10.2 Sanofi (Europe) Major Business
2.10.3 Sanofi (Europe) Influenza Vaccination Product and Solutions
2.10.4 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sanofi (Europe) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Vaccination Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Influenza Vaccination by Company Revenue
3.2.2 Top 3 Influenza Vaccination Players Market Share in 2023
3.2.3 Top 6 Influenza Vaccination Players Market Share in 2023
3.3 Influenza Vaccination Market: Overall Company Footprint Analysis
3.3.1 Influenza Vaccination Market: Region Footprint
3.3.2 Influenza Vaccination Market: Company Product Type Footprint
3.3.3 Influenza Vaccination Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Vaccination Consumption Value and Market Share by Type (2019-2024)
4.2 Global Influenza Vaccination Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Vaccination Consumption Value Market Share by Application (2019-2024)
5.2 Global Influenza Vaccination Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Influenza Vaccination Consumption Value by Type (2019-2030)
6.2 North America Influenza Vaccination Consumption Value by Application (2019-2030)
6.3 North America Influenza Vaccination Market Size by Country
6.3.1 North America Influenza Vaccination Consumption Value by Country (2019-2030)
6.3.2 United States Influenza Vaccination Market Size and Forecast (2019-2030)
6.3.3 Canada Influenza Vaccination Market Size and Forecast (2019-2030)
6.3.4 Mexico Influenza Vaccination Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Influenza Vaccination Consumption Value by Type (2019-2030)
7.2 Europe Influenza Vaccination Consumption Value by Application (2019-2030)
7.3 Europe Influenza Vaccination Market Size by Country
7.3.1 Europe Influenza Vaccination Consumption Value by Country (2019-2030)
7.3.2 Germany Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.3 France Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.5 Russia Influenza Vaccination Market Size and Forecast (2019-2030)
7.3.6 Italy Influenza Vaccination Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Vaccination Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Influenza Vaccination Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Influenza Vaccination Market Size by Region
8.3.1 Asia-Pacific Influenza Vaccination Consumption Value by Region (2019-2030)
8.3.2 China Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.3 Japan Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.4 South Korea Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.5 India Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Influenza Vaccination Market Size and Forecast (2019-2030)
8.3.7 Australia Influenza Vaccination Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Influenza Vaccination Consumption Value by Type (2019-2030)
9.2 South America Influenza Vaccination Consumption Value by Application (2019-2030)
9.3 South America Influenza Vaccination Market Size by Country
9.3.1 South America Influenza Vaccination Consumption Value by Country (2019-2030)
9.3.2 Brazil Influenza Vaccination Market Size and Forecast (2019-2030)
9.3.3 Argentina Influenza Vaccination Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Vaccination Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Influenza Vaccination Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Influenza Vaccination Market Size by Country
10.3.1 Middle East & Africa Influenza Vaccination Consumption Value by Country (2019-2030)
10.3.2 Turkey Influenza Vaccination Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Influenza Vaccination Market Size and Forecast (2019-2030)
10.3.4 UAE Influenza Vaccination Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Influenza Vaccination Market Drivers
11.2 Influenza Vaccination Market Restraints
11.3 Influenza Vaccination Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Vaccination Industry Chain
12.2 Influenza Vaccination Upstream Analysis
12.3 Influenza Vaccination Midstream Analysis
12.4 Influenza Vaccination Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Vaccination Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Influenza Vaccination Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Influenza Vaccination Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott (U.S.) Company Information, Head Office, and Major Competitors
Table 6. Abbott (U.S.) Major Business
Table 7. Abbott (U.S.) Influenza Vaccination Product and Solutions
Table 8. Abbott (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott (U.S.) Recent Developments and Future Plans
Table 10. AstraZeneca (Europe) Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca (Europe) Major Business
Table 12. AstraZeneca (Europe) Influenza Vaccination Product and Solutions
Table 13. AstraZeneca (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca (Europe) Recent Developments and Future Plans
Table 15. BioCryst Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 16. BioCryst Pharmaceuticals (U.S.) Major Business
Table 17. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
Table 18. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 20. Novartis (Europe) Company Information, Head Office, and Major Competitors
Table 21. Novartis (Europe) Major Business
Table 22. Novartis (Europe) Influenza Vaccination Product and Solutions
Table 23. Novartis (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis (Europe) Recent Developments and Future Plans
Table 25. DAIICHI SANKYO COMPANY (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 26. DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
Table 27. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
Table 28. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
Table 30. GlaxoSmithKline (Europe) Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline (Europe) Major Business
Table 32. GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
Table 33. GlaxoSmithKline (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. GlaxoSmithKline (Europe) Recent Developments and Future Plans
Table 35. Hualan Biological Engineering (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 36. Hualan Biological Engineering (Asia Pacific) Major Business
Table 37. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
Table 38. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
Table 40. Mitsubishi Tanabe Pharma (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 41. Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
Table 42. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
Table 43. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
Table 45. F. Hoffmann-La Roche (Europe) Company Information, Head Office, and Major Competitors
Table 46. F. Hoffmann-La Roche (Europe) Major Business
Table 47. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
Table 48. F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
Table 50. Sanofi (Europe) Company Information, Head Office, and Major Competitors
Table 51. Sanofi (Europe) Major Business
Table 52. Sanofi (Europe) Influenza Vaccination Product and Solutions
Table 53. Sanofi (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sanofi (Europe) Recent Developments and Future Plans
Table 55. Global Influenza Vaccination Revenue (USD Million) by Players (2019-2024)
Table 56. Global Influenza Vaccination Revenue Share by Players (2019-2024)
Table 57. Breakdown of Influenza Vaccination by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Influenza Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Influenza Vaccination Players
Table 60. Influenza Vaccination Market: Company Product Type Footprint
Table 61. Influenza Vaccination Market: Company Product Application Footprint
Table 62. Influenza Vaccination New Market Entrants and Barriers to Market Entry
Table 63. Influenza Vaccination Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Influenza Vaccination Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Influenza Vaccination Consumption Value Share by Type (2019-2024)
Table 66. Global Influenza Vaccination Consumption Value Forecast by Type (2025-2030)
Table 67. Global Influenza Vaccination Consumption Value by Application (2019-2024)
Table 68. Global Influenza Vaccination Consumption Value Forecast by Application (2025-2030)
Table 69. North America Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Influenza Vaccination Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Influenza Vaccination Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Influenza Vaccination Raw Material
Table 100. Key Suppliers of Influenza Vaccination Raw Materials
Table 1. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Vaccination Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Influenza Vaccination Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Influenza Vaccination Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott (U.S.) Company Information, Head Office, and Major Competitors
Table 6. Abbott (U.S.) Major Business
Table 7. Abbott (U.S.) Influenza Vaccination Product and Solutions
Table 8. Abbott (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott (U.S.) Recent Developments and Future Plans
Table 10. AstraZeneca (Europe) Company Information, Head Office, and Major Competitors
Table 11. AstraZeneca (Europe) Major Business
Table 12. AstraZeneca (Europe) Influenza Vaccination Product and Solutions
Table 13. AstraZeneca (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. AstraZeneca (Europe) Recent Developments and Future Plans
Table 15. BioCryst Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 16. BioCryst Pharmaceuticals (U.S.) Major Business
Table 17. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
Table 18. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 20. Novartis (Europe) Company Information, Head Office, and Major Competitors
Table 21. Novartis (Europe) Major Business
Table 22. Novartis (Europe) Influenza Vaccination Product and Solutions
Table 23. Novartis (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis (Europe) Recent Developments and Future Plans
Table 25. DAIICHI SANKYO COMPANY (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 26. DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
Table 27. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
Table 28. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
Table 30. GlaxoSmithKline (Europe) Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline (Europe) Major Business
Table 32. GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
Table 33. GlaxoSmithKline (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. GlaxoSmithKline (Europe) Recent Developments and Future Plans
Table 35. Hualan Biological Engineering (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 36. Hualan Biological Engineering (Asia Pacific) Major Business
Table 37. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
Table 38. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
Table 40. Mitsubishi Tanabe Pharma (Asia Pacific) Company Information, Head Office, and Major Competitors
Table 41. Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
Table 42. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
Table 43. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
Table 45. F. Hoffmann-La Roche (Europe) Company Information, Head Office, and Major Competitors
Table 46. F. Hoffmann-La Roche (Europe) Major Business
Table 47. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
Table 48. F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
Table 50. Sanofi (Europe) Company Information, Head Office, and Major Competitors
Table 51. Sanofi (Europe) Major Business
Table 52. Sanofi (Europe) Influenza Vaccination Product and Solutions
Table 53. Sanofi (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sanofi (Europe) Recent Developments and Future Plans
Table 55. Global Influenza Vaccination Revenue (USD Million) by Players (2019-2024)
Table 56. Global Influenza Vaccination Revenue Share by Players (2019-2024)
Table 57. Breakdown of Influenza Vaccination by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Influenza Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Influenza Vaccination Players
Table 60. Influenza Vaccination Market: Company Product Type Footprint
Table 61. Influenza Vaccination Market: Company Product Application Footprint
Table 62. Influenza Vaccination New Market Entrants and Barriers to Market Entry
Table 63. Influenza Vaccination Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Influenza Vaccination Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Influenza Vaccination Consumption Value Share by Type (2019-2024)
Table 66. Global Influenza Vaccination Consumption Value Forecast by Type (2025-2030)
Table 67. Global Influenza Vaccination Consumption Value by Application (2019-2024)
Table 68. Global Influenza Vaccination Consumption Value Forecast by Application (2025-2030)
Table 69. North America Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Influenza Vaccination Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Influenza Vaccination Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Influenza Vaccination Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Influenza Vaccination Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Influenza Vaccination Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Influenza Vaccination Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Influenza Vaccination Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Influenza Vaccination Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Influenza Vaccination Raw Material
Table 100. Key Suppliers of Influenza Vaccination Raw Materials
LIST OF FIGURES
Figure 1. Influenza Vaccination Picture
Figure 2. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Vaccination Consumption Value Market Share by Type in 2023
Figure 4. Egg Based
Figure 5. Cell Culture
Figure 6. Recombinant
Figure 7. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Influenza Vaccination Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Research Organizations Picture
Figure 11. Global Influenza Vaccination Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Vaccination Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Influenza Vaccination Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Influenza Vaccination Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Influenza Vaccination Consumption Value Market Share by Region in 2023
Figure 16. North America Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Influenza Vaccination Revenue Share by Players in 2023
Figure 22. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Influenza Vaccination Market Share in 2023
Figure 24. Global Top 6 Players Influenza Vaccination Market Share in 2023
Figure 25. Global Influenza Vaccination Consumption Value Share by Type (2019-2024)
Figure 26. Global Influenza Vaccination Market Share Forecast by Type (2025-2030)
Figure 27. Global Influenza Vaccination Consumption Value Share by Application (2019-2024)
Figure 28. Global Influenza Vaccination Market Share Forecast by Application (2025-2030)
Figure 29. North America Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 39. France Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Region (2019-2030)
Figure 46. China Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 49. India Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 63. Influenza Vaccination Market Drivers
Figure 64. Influenza Vaccination Market Restraints
Figure 65. Influenza Vaccination Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Influenza Vaccination in 2023
Figure 68. Manufacturing Process Analysis of Influenza Vaccination
Figure 69. Influenza Vaccination Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Influenza Vaccination Picture
Figure 2. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Vaccination Consumption Value Market Share by Type in 2023
Figure 4. Egg Based
Figure 5. Cell Culture
Figure 6. Recombinant
Figure 7. Global Influenza Vaccination Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Influenza Vaccination Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Research Organizations Picture
Figure 11. Global Influenza Vaccination Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Vaccination Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Influenza Vaccination Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Influenza Vaccination Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Influenza Vaccination Consumption Value Market Share by Region in 2023
Figure 16. North America Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Influenza Vaccination Revenue Share by Players in 2023
Figure 22. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Influenza Vaccination Market Share in 2023
Figure 24. Global Top 6 Players Influenza Vaccination Market Share in 2023
Figure 25. Global Influenza Vaccination Consumption Value Share by Type (2019-2024)
Figure 26. Global Influenza Vaccination Market Share Forecast by Type (2025-2030)
Figure 27. Global Influenza Vaccination Consumption Value Share by Application (2019-2024)
Figure 28. Global Influenza Vaccination Market Share Forecast by Application (2025-2030)
Figure 29. North America Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 39. France Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Influenza Vaccination Consumption Value Market Share by Region (2019-2030)
Figure 46. China Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 49. India Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Influenza Vaccination Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Influenza Vaccination Consumption Value (2019-2030) & (USD Million)
Figure 63. Influenza Vaccination Market Drivers
Figure 64. Influenza Vaccination Market Restraints
Figure 65. Influenza Vaccination Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Influenza Vaccination in 2023
Figure 68. Manufacturing Process Analysis of Influenza Vaccination
Figure 69. Influenza Vaccination Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
